Shenzhen Tyercan Biopharm
Latest round
- Angel
Last raised
- Jan 2022
Total raised
- Undisclosed
Investors
- 5
About Shenzhen Tyercan Biopharm
Based in Shenzhen, China, and established in 2017, Shenzhen Tyercan Biopharm is a pharmaceutical company that focuses on R&D of targeted drugs. The company is a national high-tech company. Moreover, the company established by returnee Doctors team. The company self-developed peptide-targeted anticancer drugs and targeted immunosuppressive drugs, taking the technologies of peptide drug conjugates (PDC) and peptide testing. Those drugs can be used to cure tumors, organ transplantation, and autoimmunity diseases. The company plans to promote preclinical studies, Investigational New Drug (IND) application, and clinical phase I/II/III trials of its multiple products.
Who invested in Shenzhen Tyercan Biopharm
5 investors across 1 round
See all investors in Shenzhen Tyercan Biopharm
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Jan 24, 2022
Amount
Undisclosed
Investors
Questions about Shenzhen Tyercan Biopharm
Who invested in Shenzhen Tyercan Biopharm?
Shenzhen Tyercan Biopharm has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Tyercan Biopharm raised?
Shenzhen Tyercan Biopharm has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Shenzhen Tyercan Biopharm last raise money?
Shenzhen Tyercan Biopharm's most recent round on record is a Angel, in Jan 2022.
What does Shenzhen Tyercan Biopharm do?
Based in Shenzhen, China, and established in 2017, Shenzhen Tyercan Biopharm is a pharmaceutical company that focuses on R&D of targeted drugs.
Where is Shenzhen Tyercan Biopharm headquartered?
Shenzhen Tyercan Biopharm is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Tyercan Biopharm?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back pharmaceuticals companies at Shenzhen Tyercan Biopharm's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Angel
Raising like Shenzhen Tyercan Biopharm? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.